JonathanTWolfeMD

PubMed

• 92 citations
  Progression-related expression of β3 integrin in melanomas and nevi
  Patricia Van Belle, Rosalie Elenitsas, Kapaettu Satyamoorthy, Jonathan T. Wolfe, DuPont Guerry
  Human Pathology. 1999-05-01
• 203 citations
  Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma
  Benjamin R. Vowels, Stuart R. Lessin, Maureen Cassin, Christine Jaworsky, Bernice M. Benoit
  The Journal of Investigative Dermatology. 1994-11-01
• 57 citations
  Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in r...
  Alain H. Rook, Christine Jaworsky, Tri Q. Nguyen, Robert A. Grossman, Jonathan T. Wolfe
  Transplantation. 1995-03-15

Journal Articles

• The Association between Melanoma and Breast Cancer and Implications for Care  
  Wolfe JT, Cutaneous Oncology Today, 1/1/2011
• Eosinophilic Fasciitis with Eosinophilic Cellulitis in a Patient with Abnormal Circulating Clonal T Cells: Increased Production of Interleukin 5 and Inhibition by Inte...  
  French LE, Shapiro M, Junkins Hopkins J, Wolfe JT, Rook AH, 1/1/2003
• Treatment of Cutaneous T Cell Lymphoma with Combined Immunomodulatory Therapy: A 14-Year Experience at a Single Institution  
  Suchin KR, Cucchiara AJ, Gottlieb SL, Wolfe JT, DeNardo BJ, Marcey WH, Bromley PG, Vittorio CC, Rook AH, Archives of Dermatology, 1/1/2002
• The Role of Skin Cancer Screening in Primary Care  
  Edman J, Wolfe JT, American Family Physician, 1/1/2000
• Progression Related Expression of Beta3 Integrin in Melanomas and Nevi  
  Van Belle PA, Elenitsas R, Satyamoorthy K, Wolfe JT, Van Belle TJ, Albelda S, Herlyn M, Elder DE, J Cutaneous Pathology, 1/1/1999
• Over expression of p53 Protein in Cutaneous T-Cell Lymphoma: Relationship to Large Cell Transformation and Disease Progression  
  Li G, Chooback L, Wolfe JT, Rook AH, Felix CA, Lessin SR, Salhany KE, J Invest Dermatol, 1/1/1998
• Cutaneous Lupus Erythematosus following Laser Induced Thermal Injury  
  Wolfe JT, Grossman D, Weinberg JM, Uberti-Benz M, Arch of Dermatol, 1/1/1997
• Cutaneous Necrosis Associated with Interferon b Injection: Report of Three Cases  
  Weinberg JM, Wolfe JT, Rastogi S, Rook AH, Spiers EM, Acta Derm Verereol, 1/1/1997
• Pathogenesis of Cutaneous T-Cell Lymphoma: Implications for Biological Response Modification  
  Rook AH, Wolfe JT, Gottlieb SL, Rastogi S, Niu Z, Lessin SR, Fox FE, Clin & Exp Immunology, 1/1/1997
• Acute Hepatitis in Parvovirus B19 Infection  
  Weinberg JM, Wolfe JT, Frattali AL, Werth VP, Naides SJ, Spiers EM, J Clin Rheumatol, 1/1/1996
• Treatment of Cutaneous T-Cell Lymphoma with Extra Corporeal Photochemotherapy at the University of Pennsylvania  
  Gottlieb S, Wolfe JT, Lessin SR, Rook AH, J Am Acad Dermatol, 1/1/1996
• Reversal of Acute Renal Allograft Rejection by Extracorporeal Photopheresis: A Case Presentation and Review of the Literature  
  Wolfe JT, Tomaszewski J, Grossman R, Naji A, Brayman K, Kobrin S, Rook AH, J Apheresis, 1/1/1996
• Successful Ultraviolet B Treatment of Psoriasis is accompanied by a Reversal of Keratinocyte Pathology and by Selective Depletion of Intraepidermal T Cells  
  Krueger JG, Wolfe JT, Nabeya RT, Vallat VP, Galleaudeau P, Heftler NS, Austin LM, Gottlieb AB, J Exp Med, 1/1/1995
• Large Cell Transformation Following Detection of Minimal Residual Disease in Cutaneous T Cell Lymphoma: Molecular and In Situ Analysis of a Single Neoplastic Cell Clos...  
  Wolfe JT, Chooback L, Finn, DT, Jaworsky C, Rook AH, Lessin SR, J Clin Oncol, 1/1/1995
• Short Contact Anthralin Treatment Augments Therapeutic Efficacy of Cyclosporine in Psoriasis: A Clinical and Pathologic Study  
  Gottlieb SL, Johnson R, Vallat VP, Wolfe JT, Gottlieb AB, Krueger JG, J Am Acad Dermatol, 1/1/1995
• De Novo Development of Psoriasis in Patients Receiving Interferon A for Erythrodermic Cutaneous T Cell Lymphoma: A Report of Two Cases and Review of the Literature  
  Wolfe JT, Singh A., Lessin SR, Jaworsky C, Rook AH, J Am Acad Dermatol, 1/1/1995
• Beneficial Effect of Low Dose Systemic Retinoid in combination with Topical Tretinoin for the Treatment and Prophylaxis of Premalignant and Malignant Skin Lesions in R...  
  Rook AH, Jaworsky C, Nguyen T, Grossman RA, Wolfe JT, Witmer W, Klingman A, Transplantation, 1/1/1995
• Interleukin 12 Reverses Cytokine and Immune Abnormalities in Sezary Syndrome  
  Rook, AH, Kubin M, Cassin M, Vonderheid EC, Vowels BR, Wolfe JT, Singh A, Trinchieri A, Lessin SR, J Immunology, 1/1/1995
• Role of Extracorporeal Photopheresis in the Treatment of Cutaneous T Cell Lymphoma, Autoimmune Disease and Allograft Rejection  
  Rook AH, Wolfe JT, J Clin Apheresis, 1/1/1994
• Th2 Cytokine mRNA Expression in Peripheral Blood and Skin in Cutaneous T Cell Lymphoma: Marker of Disease Progression  
  Vowels B, Lessin SR, Cassin M, Jaworsky C, Benoit B, Wolfe JT, Rook AH, J Invest Dermatol, 1/1/1994
• Immunomodulation by Photopheresis: Treatment of Cutaneous T Cell Lymphoma, Autoimmune Disease and Allograft Rejection  
  Wolfe JT, Lessin SR, SinghA, Rook AH, Int J Artificial Organs, 1/1/1994
• PUV Bath Therapy Strongly Suppresses Immunological and Epidermal Activation in Psoriasis A Possible Cellular Basis for Remittive Therapy  
  Vallat VP, Gilleaudeau P, Battat L, Wolfe JT, Nabeya R, Heftle N, Hodak E, Carter M, Gottlieb AB, Krueger J, J Exp Med, 1/1/1994
• Join now to see all

Books/Book Chapters

• Clinical Oncology 
  Chapter: Nonmelanoma Skin Cancers: Basal Cell and Squamous Cell Carcinoma 
  Wolfe JTEditors: Abeloff MD, Armitage JO, Lichter AS, Neiderhuber JE.New York, NY2000
• Current Opinion in Oncology 
  Chapter: The Role of Screening in the Management of Skin Cancer 
  Page 123 - 128Editors: Wolfe JT, Abeloff MD.1999
• Clinical Simulations in the Management of Dermatologic Infections: #4 in a Series 
  Chapter: Dermatophytic Infections and Skin Cancer in Immunocompromised Patients: Clinical Simulations in the Management of Dermatologic Infections 
  Wolfe JT, Chan EF, Leyden JJMedical Age Publishing, Norwalk, CT1997
• Therapy of Moderate to Severe Psoriasis 
  Chapter: A Guide to Using PUVA Bath Therapy with 9-Methoxypsoralen 
  Page 39 - 55Vallat V, Galleaudeau P, Battat L, Wolfe JT, Heftler N, Gottlieb S, Hodak E, Gottlieb AB, Krueger JGEditors: GD Weinstein and AB Gottlieb.National Psoriasis Foundation, Portland, OR1995
• Join now to see all

Abstracts/Posters

• Ki-67 Expression and Mitotic Rate as Prognostic Factors for Metastasis in Patients with Thin Primary Melanomas
  Gimotty PA, Elder DE, Van Belle P, Murray T, Ming M, Raines S, Hotz S, Synnestvedt M, Schuchter L, Wolfe JT, Guerry D, Proc Am Assoc Cancer Research, 1/1/2002
• Treatment of Cutaneous T Cell Lymphoma with Extracorporeal Photochemotherapy at the University of Pennsylvania
  Wolfe JT, Gottlieb S, Fox F, DeNardo B, Macey W, Bromley P, Lessin S, Rook A, J Invest Dermatol, 1/1/1995
• Over Expression of p53 Protein n Cutaneous T Cell Lymphoma: Relationship to Large Cell Transformation and Disease Progression
  Chooback L, Felix CA, Salhany KE, Wolfe JT, Salvatore R, Rook AH, Lessin Sr, J Invest Dermatol, 1/1/1995
• P53 Protein Expression in Cutaneous T Cell Lymphoma: A Relationship to Disease Progression
  Salhany KE, Wolfe JT, Salvatore R, Rook AH, Lessin SR, J Invest Dermatol, 1/1/1995
• Large Cell Transformation in Cutaneous T Cell Lymphoma (CTCL): Demonstration of a Single Neoplastic T Cell Clone Expressing the Identical T Cell Receptor
  Wolfe JT, Chooback L, Finn DT, Benoit BM, Jaworsky C, Rook AH, Lessin SR, J Invest Dermatol, 1/1/1994
• Interleukin-12 Reverses Cytokine and Immune Abnormalities of Sezary Syndrome
  Rook AH, Kubin M, Vonderheid EC, Cassin M, Vowels BR, Wolfe JT, Trinchieri G, Lessin Sr, J Invest Dermatol, 1/1/1994
• Is Psoriasis Primarily a Disorder of Epidermal CD4/CD8 T Lymphocytes and Epidermal Regenerative Activation?
  Wolfe JT, Nabeya R, Vallat V, Galleaudeau P, Heftler N, Krueger J, Gottlieb AB, J Invest Dermatol, 1/1/1993
• Cyclosporine/Anthralin Combination therapy in the Treatment of Psoriasis
  Heftler N, Wolfe JT, Galleaudeau P, Vallat V, Carter M, Krueger J, Gottlieb AB, J Invest Dermatol, 1/1/1993
• Join now to see all

Other

• Who Needs UV Education and Who Should Provide It? 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2018
• New NMSC Guidelines Highlight Options and Need for More Research 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2018
• Total Body Skin Exams: Don�t Abandon Them 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2017
• High Dose Ipilimumab Shows Benefits in Advanced Melanoma: Implications for Care 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2017
• Sunscreen Perceptions, Promotion, and Use 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2017
• Invasive Melanoma: Incidence, Mortality continues to climb 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2017
• Characterizing Melanoma Risk Clinically 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2017
• Melanoma and the Predictive Value of Nevi: Unexpected findings 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2016
• Risks of Multiple Primary Melanomas 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2016
• Pregnancy and Melanoma: What We Know About the Risks 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2016
• Reassessing topical 5-Fluorouracil for AK Management 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2016
• Viagra and Aggressive Melanoma: is there a Link? 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2016
• Multiple Primary Melanomas 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2016
• Understandings of Melanoma Spread and Aggression 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2016
• Assessing the Need for Re Excision in Mild to Moderate Dysplastic Nevi 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2015
• Recently Passed Law Clears Way for New Sunscreen Ingredients 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2015
• Pruritus: A Marker For Cancer? 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2015
• Can Vitamin B3 Reduce Recurrence of NMSC? 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2015
• Update: Oral Therapies for the Treatment of BCC 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2015
• The Growing Genetic Profile of Melanoma 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2015
• Prevention Efforts: Where We Stand 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2015
• The Molecular Era of Melanoma 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2014
• Melanoma Treatment Landscape Evolves 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2014
• Histopathological Assessment of Atypical Pigmented Lesions 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2014
• Regression in Primary Melanomas: Histologic Factors and Prognosis 
  Wolfe JT, Practical Dermatology (Editor, Oncology Watch)
  1/1/2014
• Join now to see all